New Steps for Compliance: A Closer Look at the DOJ’s Revised Corporate Compliance Guide

Overview



On June 1, 2020, the Criminal Division of the Department of Justice (DOJ) issued updates to its “Evaluation of Corporate Compliance Program” guidance. This update reflects the agency’s evolving views on compliance program elements and activities, as well as the questions DOJ asks when assessing the effectiveness of an organization’s compliance program. It can also be useful for organizations in evaluating their own compliance program effectiveness.

This program, featuring insights from our white collar, healthcare, and corporate governance teams, will include:

  • Analysis of DOJ’s revised “Evaluation of Corporate Compliance Programs” guidance and the agency’s refined perspective
  • Practical implications for compliance officers, in-house counsel, and audit & compliance committees when evaluating and operating compliance programs
  • Other important developments relating to corporate compliance programs

We want to ensure we address the issues of most importance to our participants, and we encourage you to submit your questions for the panel in advance during registration.

Registration Information

12:00 pm – 1:00 pm (EST)

Zoom webinar.

Details sent upon registration.

Dig Deeper

Paris, France / McDermott Event / October 18, 2022

European Healthcare & Life Sciences Forum

London, United Kingdom / McDermott Event / September 29, 2022

HPE Europe 2022

San Diego, CA / McDermott Event / June 14, 2022

BIO BASH 2022

Washington, DC / FDLI / June 14 - 15, 2022

Exploring Advanced Topics in Food and Drug Law

Webinar / FDLI / May 24 - 25, 2022

Legal and Practical Issues in Cannabis Regulation

Get In Touch